Company intelligence / Profile preview
Apteeus
Roubaix, Hauts-de-France, France
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
01
Overview
Apteeus has developed proprietary technologies enabling rapid identification of new therapeutic uses for existing drugs, particularly targeting rare monogenic diseases. The company leverages patient-derived cells and high-throughput screening to identify candidates suitable for compassionate use or further development. No published results from late-stage clinical trials are available; the company’s impact centers on accelerated preclinical discovery and early access programs.
- Therapeutic areas
- Rare DiseasesOther
- Modalities
- Small molecules (focus on approved drugs for repositioning)
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
Institut Pasteur de Lille/R&D capabilities within the instituteCollaborations with patient associations, doctors, academic teams, pharmaceutical companies.
Beyond the preview
Go deeper on Apteeus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apteeus.